drugset / Trial / NCT00047788
Efficacy Study of ZD6474 to Treat Multiple Myeloma Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The primary objective is to assess the efficacy of ZD6474 when given orally to patients with relapsed multiple myeloma. A minimum of 15 and a maximum of 30 evaluable patients will be entered on study
Timeline
- Start
- 2002-10
- Primary completion
- —
- Completion
- 2004-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vandetanib | Small molecule | — | Oral |